This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Controlled Clinical Trial

. 2011 Feb;213(2-3):653-5.

doi: 10.1007/s00213-010-1993-6. Epub 2010 Aug 21.

Does agomelatine block 5-HT2C receptors in humans?

Ann L Sharpley, Nancy B Rawlings, Susannah Brain, Sarah F B McTavish, Philip J Cowen

PMID: 20730417
DOI: 10.1007/s00213-010-1993-6

Controlled Clinical Trial

Does agomelatine block 5-HT2C receptors in humans?

Ann L Sharpley et al. Psychopharmacology (Berl). 2011 Feb.

. 2011 Feb;213(2-3):653-5.

doi: 10.1007/s00213-010-1993-6. Epub 2010 Aug 21.

Authors

Ann L Sharpley, Nancy B Rawlings, Susannah Brain, Sarah F B McTavish, Philip J Cowen

PMID: 20730417
DOI: 10.1007/s00213-010-1993-6

No abstract available

PubMed Disclaimer

Comment in

The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?
Norman TR. Norman TR. Psychopharmacology (Berl). 2012 May;221(1):177-8; author reply 179. doi: 10.1007/s00213-012-2656-6. Epub 2012 Feb 15. Psychopharmacology (Berl). 2012. PMID: 22349274 No abstract available.

Similar articles

The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?
Norman TR. Norman TR. Psychopharmacology (Berl). 2012 May;221(1):177-8; author reply 179. doi: 10.1007/s00213-012-2656-6. Epub 2012 Feb 15. Psychopharmacology (Berl). 2012. PMID: 22349274 No abstract available.
Major depressive disorder, anhedonia and agomelatine: an open-label study.
Di Giannantonio M, Di Iorio G, Guglielmo R, De Berardis D, Conti CM, Acciavatti T, Cornelio M, Martinotti G. Di Giannantonio M, et al. J Biol Regul Homeost Agents. 2011 Jan-Mar;25(1):109-14. J Biol Regul Homeost Agents. 2011. PMID: 21382280 Clinical Trial.
Agomelatine prevents relapse in patients with major depressive disorder without evidence of a discontinuation syndrome: a 24-week randomized, double-blind, placebo-controlled trial.
Goodwin GM, Emsley R, Rembry S, Rouillon F; Agomelatine Study Group. Goodwin GM, et al. J Clin Psychiatry. 2009 Aug;70(8):1128-37. doi: 10.4088/JCP.08m04548. Epub 2009 Aug 11. J Clin Psychiatry. 2009. PMID: 19689920 Clinical Trial.
Mode of action of agomelatine: synergy between melatonergic and 5-HT2C receptors.
Racagni G, Riva MA, Molteni R, Musazzi L, Calabrese F, Popoli M, Tardito D. Racagni G, et al. World J Biol Psychiatry. 2011 Dec;12(8):574-87. doi: 10.3109/15622975.2011.595823. Epub 2011 Oct 14. World J Biol Psychiatry. 2011. PMID: 21999473 Review.
[Development of a new antidepressant : agomelatine].
Mocaër E, Delalleau B, Boyer PA, de Bodinat C. Mocaër E, et al. Med Sci (Paris). 2005 Oct;21(10):888-93. doi: 10.1051/medsci/20052110888. Med Sci (Paris). 2005. PMID: 16197911 Review. French.

See all similar articles

Cited by

Adjunctive agomelatine therapy in the treatment of acute bipolar II depression: a preliminary open label study.
Fornaro M, McCarthy MJ, De Berardis D, De Pasquale C, Tabaton M, Martino M, Colicchio S, Cattaneo CI, D'Angelo E, Fornaro P. Fornaro M, et al. Neuropsychiatr Dis Treat. 2013;9:243-51. doi: 10.2147/NDT.S41557. Epub 2013 Feb 15. Neuropsychiatr Dis Treat. 2013. PMID: 23430979 Free PMC article.
The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice.
De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva MA, Martinotti G, di Giannantonio M. De Berardis D, et al. Int J Mol Sci. 2013 Jun 13;14(6):12458-83. doi: 10.3390/ijms140612458. Int J Mol Sci. 2013. PMID: 23765220 Free PMC article. Review.
The effect of agomelatine on 5HT(2C) receptors in humans: a clinically relevant mechanism?
Norman TR. Norman TR. Psychopharmacology (Berl). 2012 May;221(1):177-8; author reply 179. doi: 10.1007/s00213-012-2656-6. Epub 2012 Feb 15. Psychopharmacology (Berl). 2012. PMID: 22349274 No abstract available.
Effects of typhoid vaccine on inflammation and sleep in healthy participants: a double-blind, placebo-controlled, crossover study.
Sharpley AL, Cooper CM, Williams C, Godlewska BR, Cowen PJ. Sharpley AL, et al. Psychopharmacology (Berl). 2016 Sep;233(18):3429-35. doi: 10.1007/s00213-016-4381-z. Epub 2016 Aug 9. Psychopharmacology (Berl). 2016. PMID: 27503474 Free PMC article. Clinical Trial.
A benefit-risk assessment of agomelatine in the treatment of major depression.
Howland RH. Howland RH. Drug Saf. 2011 Sep 1;34(9):709-31. doi: 10.2165/11593960-000000000-00000. Drug Saf. 2011. PMID: 21830835 Review.

See all "Cited by" articles

References

1. Psychiatry Res. 1991 Sep;38(3):227-36 - PubMed
1. Clin Endocrinol (Oxf). 2005 Sep;63(3):298-304 - PubMed
1. J Psychopharmacol. 1989 Jan;3(3):125-9 - PubMed
1. J Pharmacol Exp Ther. 2003 Sep;306(3):954-64 - PubMed
1. Biol Psychiatry. 1995 Jan 15;37(2):85-98 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Springer